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Abstract
Background: Normal urinary bladder function requires bidirectional molecular communication between urothelium,
detrusor smooth muscle and sensory neurons and one of the key mediators involved in this intercellular signaling is ATP.
Ectonucleotidases dephosphorylate nucleotides and thus regulate ligand exposure to P2X and P2Y purinergic receptors.
Little is known about the role of these enzymes in mammalian bladder despite substantial literature linking bladder diseases
to aberrant purinergic signaling. We therefore examined the expression and distribution of ectonucleotidases in the mouse
bladder since mice offer the advantage of straightforward genetic modification for future studies.
Principal Findings: RT-PCR demonstrated that eight members of the ectonucleoside triphosphate diphosphohydrolase
(NTPD) family, as well as 59-nucleotidase (NT5E) are expressed in mouse bladder. NTPD1, NTPD2, NTPD3, NTPD8 and NT5E
all catalyze extracellular nucleotide dephosphorylation and in concert achieve stepwise conversion of extracellular ATP to
adenosine. Immunofluorescent localization with confocal microscopy revealed NTPD1 in endothelium of blood vessels in
the lamina propria and in detrusor smooth muscle cells, while NTPD2 was expressed in cells localized to a region of the
lamina propria adjacent to detrusor and surrounding muscle bundles in the detrusor. NTPD3 was urothelial-specific,
occurring on membranes of intermediate and basal epithelial cells but did not appear to be present in umbrella cells.
Immunoblotting confirmed NTPD8 protein in bladder and immunofluorescence suggested a primary localization to the
urothelium. NT5E was present exclusively in detrusor smooth muscle in a pattern complementary with that of NTPD1
suggesting a mechanism for providing adenosine to P1 receptors on the surface of myocytes.
Conclusions: Ectonucleotidases exhibit highly cell-specific expression patterns in bladder and therefore likely act in a
coordinated manner to regulate ligand availability to purinergic receptors. This is the first study to determine the expression
and location of ectonucleotidases within the mammalian urinary bladder.
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Introduction
ATP is increasingly recognized as an important signaling
mediator in the urinary bladder and is secreted both by the
bladder epithelium or urothelium [1–3] and by neurons.
Urothelium releases ATP both lumenally into the urine space
and serosally. The mechanism underlying this release is not well
understood but kinetic studies have shown that ATP secretion is
markedly stimulated by stretch, indicating mechanically sensitive
signaling pathways in response to bladder filling [2,4]. ATP
released lumenally from umbrella cells is thought to play a role in
autocrine signaling while release from the serosal surfaces permits
interaction with stromal elements including afferent neurons and
possibly the detrusor as well [2,5]. ATP is also released along with
norepinephrine by postganglionic parasympathetic nerves that
innervate the bladder smooth muscle resulting in a biphasic
mechanical response that consists of an initial rapid twitch,
followed by a sustained contraction [6].
Upon release, ATP can bind to purinergic receptors of the P2X
and P2Y families and initiate ion transport or G-protein-coupled
receptor signaling, respectively. P2X receptors, P2X1, P2X2,
P2X3, P2X5, P2X6 and P2X7 are differentially expressed
throughout the bladder [7] and loss of P2X3 from afferent nerve
fibers in a knockout mouse was shown to alter voiding behavior by
shifting the micturition reflex to greater fill volumes [8]. P2Y2 and
P2Y4 also appear to be expressed [9] indicating a diverse
repertoire of purinergic responsive receptors throughout all tissue
elements of the bladder. Furthermore, abnormalities in ATP
release and in purinergic receptor expression have been noted in
numerous studies of human bladder disease as well as in animal
models of bladder pathology. These include interstitial cystitis [10–
12], urinary urgency and incontinence [13], bladder inflammation
[14], spinal cord injury-induced bladder dysfunction [15], detrusor
overactivity [16–17] and outlet obstruction [18–20].
While much research has focused on P1 and P2 receptors,
purinergic signaling is also critically regulated by ectonucleotidases,
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enzymes act to limit, both temporally and quantitatively, the
exposure of P2 receptors to their ligands [21]. They also preclude
desensitization responses resulting from overstimulation. Further-
more, stepwise conversion creates potent metabolites, like ADP and
adenosine, which may then continue to act through other receptors
with different affinities and locations [22]. There are four main
families of ectonucleotidases; NTPDs (ectonucleoside triphosphate
diphosphohydrolases), NPPs (nucleotide pyrophosphatase/phos-
phodiesterases), alkaline phosphatases and ecto-59-nucleotidase
(NT5E). The families differ primarily in their substrate specificities,
with NTPDs highly specific for ATP/UTP/ADP/UDP [21] while
NPPs [23–24] catalyze phosphohydrolysis on a broader range of
substrates including lysophospholipids and choline phosphate esters
[22,25–27]. Alkaline phosphatases are even more promiscuous with
broad substrate specificities that overlap with those of the NPPs.
Dysregulation of nucleotide metabolism and alterations to the
activities of ectonucleotidases has been shown convincingly in many
pathological conditions including diabetes, hypertension, acute
stroke, chronic renal failure, cancer, myocardial infarction,
leukemia and epilepsy [21,28–29].
The presence of ectonucleotidases in bladder has not been
studied systematically; however their existence was inferred, since
the half-life of ATP is very different depending on which side of
the urothelium it is released from. In Ussing chamber studies,
Lewis and Lewis showed that both constitutive and stretch-
induced ATP release from the luminal surface of rabbit bladders
increase ATP concentration in a linear fashion with continuous
accumulation, whereas serosal ATP rises and then plateaus – the
kinetics of which are consistent with its initial release and then
subsequent consumption [2].
Our long term goal is to develop an in-depth understanding of
the regulation of purinergic signaling in bladder and its
importance to normal and abnormal bladder function. Since
secreted nucleotides are potent stimulators which may exert both
autocrine and paracrine effects, our focus in these experiments was
to determine the expression and location of cell-surface ecto-
hydrolytic members of the NTPD family (NTPD1, -2, -3, and -8).
Furthermore, as this group is not capable of completing the final
phosphohydrolysis step which results in production of adenosine –
another important signaling molecule, we also characterized tissue
distribution of NT5E in bladder. Our findings suggest specific and
synergistic mechanisms for the control of nucleotide availability
throughout the stratified layers of the bladder.
Materials and Methods
Animals
Mice used in this study were C57BL/6J mice (19–21 g) from
Charles River Laboratories (Wilmington, MA). Mice were
euthanized by inhalation of 100% CO2. After euthanasia and
thoracotomy, the bladders were rapidly excised and processed as
described below. All animal studies were carried out with the
approval of the Beth Israel Deaconess Medical Center Institutional
Animal Care and Use Committee (Protocol #051-2009).
Antibodies and labeled probes used for
immunofluorescence (IF) and immunoblotting (IB)
Affinity-purified monoclonal rat anti-NTPD1 antibody (IF),
affinity-purified polyclonal sheep anti-NTPD2 antibody (IF/IB),
affinity-purified polyclonal sheep anti-NTPD3 antibody (IB) and
affinity-purified monoclonal rat anti-NT5E antibody (IB) were
purchased from R&D systems (Minneapolis, MN). Affinity-
purified polyclonal rabbit anti-NTPD8 (IF/IB) was purchased
from Sigma (St. Louis, MO). Affinity-purified polyclonal goat anti-
NTPD8 antibody (IF) and anti-aquaporin 3 (IF) antibodies were
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Affinity purified goat polyclonal anti-CGRP antibody was
purchased from ABCAM Inc. (Cambridge, MA). The following
antibodies were from SCR’s laboratory: affinity-purified polyclon-
al rabbit anti-NTPD1 antibody (IB), affinity-purified polyclonal
rabbit anti-NTPD2 antibody (IF/IB); affinity-purified polyclonal
rat anti-NT5E antibody (IF). Antibodies to FSP1 and aSMA were
kind gifts from the laboratory of Dr. Raghu Kalluri (Beth Israel
Deaconess Medical Center). Secondary donkey anti-rabbit/goat/
rat antibodies conjugated to Alexa 488 or horseradish peroxidase
(HRP), and Topro-3 and rhodamine-phalloidin were purchased
from Invitrogen-Molecular Probes (Carlsbad, CA).
RT-PCR analysis
Whole bladder RNA was extracted by a QIAGEN RNeasy Mini
kit (Valencia, CA). RNA samples were treated with DNase I to
remove potential genomic DNA contamination, and control
reactions were performed in the absence of reverse transcriptase
or in the presence of a control primer pair. Reverse transcription
was carried out according to instructions for RETROscript
(Ambion, Austin, TX). Primers were designed using Primer3
software (http://frodo.wi.mit.edu/primer3/) and standard PCR
conditionswereasfollows:95uC/10 minthen 35cyclesof95u/30 s;
50–60u/30 s; 72u/60 s followed by 72u/10 min. Optimal annealing
temperature was experimentally determined. Primer pairs for each
NTPD isoform are shown in Table 1. PCR products were run on a
2.0% agarose gel containing ethidium bromide to visualize the PCR
products. Products were compared to a 100-bp ladder (PGC
Scientific,Frederick,MD),whichwasused toestimatethesizeofthe
reaction products.
Western blot analysis of ectonucleotidases in bladder
Excised bladders were put in 1 ml ice cold radio-immunopre-
cipitation assay buffer (RIPA; 50 mM Tris pH 8.0, 150 mM
NaCl, 1% v/v NP-40, 0.5% w/v deoxycholic acid, 0.1% w/v
SDS) containing Complete Mini Protease Inhibitor Cocktail
tablets (Roche, Germany). Proteins were resolved by SDS-PAGE
and transferred to Immun-Blot PVDF membrane (BioRad
Laboratories, Hercules, CA), and the blots were probed with
specific antibodies as described earlier, followed by the appropriate
species-specific secondary antibodies conjugated to HRP. Bands
were detected using ECL Plus Western Blotting reagents (GE
Healthcare, Piscataway, NJ) and CL-X Posure film (Thermo
Scientific, Rockford, Il). The film was developed, scanned and
images were contrast corrected with Photoshop (San Jose, CA),
before importing into Adobe Illustrator CS3 (San Jose, CA).
Immunofluorescence analysis of ectonucleotidases in
bladder
Excised bladders were fixed in 4% (w/v) paraformaldehyde
dissolved in 100 mM sodium cacodylate (pH 7.4) buffer for 2 h at
room temperature. In some cases, tissue was fixed by 100%
methanol (4 ˚C) for 5 min. Fixed tissue was cut into small pieces
with a razor blade, cryoprotected, frozen, sectioned (5 mm), and
incubated with primary antibodies (1:100 –1:500 dilution) for 2 h
at room temperature as described previously [30]. After washing
away unbound primary antibody, the sections were incubated
with a mixture of Alexa 488-conjugated secondary antibody
(diluted 1:100), rhodamine-phalloidin (1:50), and Topro-3
(1:1,000). The sections were washed with PBS, postfixed with
4% (wt/vol) paraformaldehyde, and mounted under coverslips
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immunofluorescent localization data shown are representative
images of staining performed on at least three individual
bladders. As bladder is a highly distensible tissue, bladder
sections prepared from individual animals varied greatly in tissue
shape, folding and thickness, making quantitation with image
analysis problematic. However, the clear architecture of the
bladder, with readily defined layers and of structures within layers
e.g. blood vessels, allowed us to assess the reproducibility of
cellular expression with confidence. There was little variability
noted between expression patterns from animal to animal.
Scanning laser confocal analysis of fluorescently labeled
cells
Imaging was performed on a Zeiss LSM-510 confocal
microscope equipped with argon and green and red helium-neon
lasers (Thornwood, NY). Images were acquired by sequential
scanning with a 63X (1.4 numerical aperture) planapochromat oil
objective and the appropriate filter combinations. Serial (z)
sections were captured with a 0.25 mm step size. The images
(512 & 512 pixels) were saved as TIFF files. Serial sections were
projected into one image using LSM-510 software. The contrast
level of the final images was adjusted in Adobe Photoshop, and the
images were imported into Adobe Illustrator CS3.
Results
Expression of all eight members of the NTPDase family and 59-
nucleotidase (NT5E) were examined in whole bladder extracts
(Fig. 1). A broad expression profile at the level of mRNA for all of
these enzymes was observed suggesting the presence of complex
cellular and tissue regulation of nucleotide availability as well as a
substrate scavenging capability.
Immunoblotting of whole bladder lysates for NTPD1, -2, -3, -8
and NT5E demonstrated that all five proteins were detected at or
Table 1. Primers used for PCR of Nucleotidase Enzymes.
Enzyme Sequence of Primers (59-39) Expected Product size (bp)
NTPD1 TTTAGCGTTTTGTGTGGTTTTATATGTT 444
CTGCCAAGTTCTTGGTAATAGAATGTTA
NTPD2 AACCAGTCCATCTGAAGATCCAGATAAT 410
AGTAGAAAGCAGAAAAGGCTATGAAGTT
NTPD3 TATTTTTATTTTGCAGCGTGTATTTGTT 479
CATAACTTTTATGTCTATGGGCATTTTG
NTPD4 GCAGGAAGAAGTAGCTAAAAACCTGTTA 432
CAGTAGTAGAACTCAGAGAAGCCGTAGA
NTPD5 AAATCCTCAACCTTTTTAACTTTTCTCA 570
ACAGTTCAGTTTTATTTATGGCTCCTCT
NTPD6 CTAAGCAACACATTCCTTATGATTTCTG 599
GACTTCTGATACTCTACTGGCACACAG
NTPD7 GTGTGTTGAGAGATCTAGTCAGAAGTCC 556
TAAATACTAAAACAGATGCAGCGAAAAC
NTPD8 GGACTAGGTAGAAACCAAGCTGAAGTAG 506
CAACTTGATCTATATTCTGGGATTGATG
NT5E GCTAGATATCAAGACTCACACACACAAA 526
CACAGGAGTTAATAAGAACCAGTGTTGT
doi:10.1371/journal.pone.0018704.t001
Figure 1. Expression of ectonucleotidases in mouse bladder by
RT-PCR. Expression of ectonucleotidases was detected by RT-PCR from
total RNA isolated from mouse bladder. Specific primers for each
enzyme are given in Table 1. RT-PCR reaction products were resolved
on 2% agrose gels and visualized by staining with ethidium bromide.
Numbers above or beneath the DNA bands are expected product sizes
(in bp). A) ENTPD family, B) NT5E.
doi:10.1371/journal.pone.0018704.g001
Ectonucleotidases in Mammalian Bladder
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18704Figure 2. Western blotting for four ectoenzymes of the NTPD family and NT5E. Lysates of mouse bladder (25 mg protein/lane) were
resolved by SDS-PAGE, and Western blots were probed with antibodies specific for five ectonucleotidases. Protein bands of the correct molecular
weight were detected for each enzyme.
doi:10.1371/journal.pone.0018704.g002
Figure 3. Immunolocalization of NTPD1 in different regions of the bladder. Cryosections of mouse bladders were labeled with antibodies
to NTPD1 (green), rhodamine phalloidin to label the actin cytoskeleton (red) and Topro-3 to label nuclei (blue). Color merged panels are shown on
the right. A) NTPD1 staining at the level of the urothelium; white arrows indicate tight junctions between superficial umbrella cells, B) NTPD1 staining
at the level of the lamina propria, C) NTPD1 staining at the level of the detrusor smooth muscle. White scale bars =10 mm.
doi:10.1371/journal.pone.0018704.g003
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59 kDa, 54 kDa and 64 kDa respectively (Fig. 2). NTPD1 and
NTPD3 migrate somewhat higher than predicted and we attribute
this to glycosylation or other post-translational modifications.
Immunoblotting confirmed that these antibodies exhibited high
specificity for the target antigens with little cross-reactivity to other
proteins. Variability in expression levels between animals was
assessed by running triplicate bladders (from three individuals) and
quantitating band density for all five enzymes. When normalized
to b actin staining, the % coefficient of variation (standard
deviation/mean*100) was less than 15% for all (data not shown).
Immunostaining of frozen bladder sections was performed for
all five proteins of interest. By counterstaining actin with
rhodamine-phalloidin (shown as red staining in middle panels,
Figs. 3, 4, 6, 7, 8) we are able to clearly identify cell layers and
tissue boundaries throughout the bladder. Confocal immunoflu-
orescent laser scanning microscopy revealed that NTPD1 is
expressed at high levels in endothelium of vascular elements
occurring prominently within the lamina propria and is also
present throughout the detrusor smooth muscle (Fig. 3b and 3c).
There was no evidence for NTPD1 in the urothelium which is
typically three cell layers deep (Fig. 3a). Merged panels on the right
show that the protein is in or near plasma membranes as expected.
NTPD2 was also absent from the urothelium (Fig. 4a) but was
distributed differentially in the lamina propria (Fig. 4b). The
merged images in Fig. 4a and 4b show a region immediately
subjacent to urothelium which is actin positive but NTPD2-
negative (see asterisks). In the more distal region of the lamina
propria, dispersed but interlinked cells with non-uniform mor-
phology are NTPD2-positive. This positive staining pattern
extends deep into the detrusor in an organized filamentous
pattern which clearly delineates and surrounds smooth muscle
bundles (Fig. 4c). These cells exhibit narrow elongated and
branched cell processes. We therefore explored the possibility that
NTPD2 positive cells were fibroblasts, myofibroblasts or neuronal
in origin by co-staining with antibodies for fibroblast-specific
protein-1 (FSP1; Fig. 5a), a-smooth muscle actin (aSMA; Fig. 5b)
and calcitonin gene related peptide (CGRP; Fig. 5c) respectively.
The merged images shown in Fig. 5 clearly illustrate that NTPD2
does not colocalize with any of these three cell markers. FSP1- and
aSMA-positive cells were predominantly found in the region of the
lamina propria proximate to the urothelium. aSMA staining also
Figure 4. Immunolocalization of NTPD2 in different regions of the bladder. Cryosections of mouse bladders were labeled with antibodies
to NTPD2 (green), rhodamine phalloidin to label the actin cytoskeleton (red) and Topro-3 to label nuclei (blue). Color merged panels are shown on
the right. A) NTPD2 staining at the level of the urothelium, B) NTPD2 staining at the level of the lamina propria; white asterisks (*) indicate areas
positive for actin but negative for NTPD2 in the lamina propria. C) NTPD2 staining at the level of the detrusor smooth muscle. White scale
bars =10 mm.
doi:10.1371/journal.pone.0018704.g004
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Coimmunostaining of neurons revealed that NTPD2 expressing
cells are distinct, however in Fig. 5c it can be seen that there is a
close association between a well defined neuron and surrounding
NTPD2 positive cells. Endothelia did not express NTPD2, in
contrast to the expression pattern seen for NTPD1 (Fig. 3b).
The urothelium is a major source of ATP released in bladder
[1–4] therefore we were interested to know if any of the NTPDases
were expressed by these cells. Fig. 6 shows that NTPD3 is
specifically expressed in the urothelium and is differentially
localized to the plasma membranes of intermediate and basal
cells (Fig. 6a and 6d). The presence of lateral actin staining and
corresponding tight junctions in the superficial umbrella cells can
be seen in the top middle panel (Fig. 6a). However, there is little
evidence for colocalization of NTPD3 at lateral borders of the
umbrella cells, indicating that the superficial cells of the
urothelium are unlikely to express this enzyme. Antibody staining
within the lamina propria is localized to cells within blood vessels
and detrusor shows no evidence for NTPD3. A different primary
antibody to NTPD3 confirmed the intermediate and basal cell
distribution of NTPD3 (Fig. 6d) by precise colocalization with
aquaporin 3, a marker of these cell membranes.
NTPD8 immunostaining of bladder showed a diffuse relatively
non-differentiated signal throughout several regions and there was
little evidence for a concentration at cell boundaries (Fig. 7a).
There is however a suggestion from the merged images that
NTPD8 may be present in the superficial cells of the urothelium
but the lack of clear membrane localization for this surface enzyme
requires caution in interpretation. To demonstrate the efficacy of
the antibody, liver sections were immunostained as a positive
control (Fig. 7b). Mouse liver showed specific and higher intensity
staining patterns with appropriate cell border localization to
canaliculi. A different primary antibody to NTPD8 was also tried
but gave identical staining patterns on both bladder and liver
sections (not shown). We conclude that expression of NTPD8 may
be low and that antibody staining is not sufficiently sensitive to
define its location with certainty. RT-PCR (Fig. 1) supports this
conclusion with NTPD8 signal lower than for other family
members.
NT5E which is responsible for the conversion of AMP to
adenosine was clearly absent from urothelium (Fig. 8a) and from
lamina propria (Fig. 8b) but was present throughout detrusor
smooth muscle in a pattern very similar to that seen for NTPD1
(Fig. 8c).
Figure 5. NTPD2 does not colocalize with fibroblasts, myofibroblasts or neurons. Cryosections of mouse bladders were coimmunostained
with NTPD2 (green) and antibodies to marker proteins for A) fibroblasts – FSP1 (red), B) myofibroblasts – aSMA (red) and C) afferent nerves – CGRP
(red). Nuclei are blue and color merged panels are shown on the right. Scale bars =10 mm.
doi:10.1371/journal.pone.0018704.g005
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The importance of purinergic signaling for urinary bladder
function has become clear, with a broad spectrum of bladder
pathologies now known to exhibit aberrant purinergic metabolism.
ATP release from the urothelium is significantly elevated in aging
[31], interstitial cystitis [10–11], in spinal cord injury [15], during
inflammation [14] and in syndromes of detrusor overactivity
resulting in urgency and/or incontinence [32]. Furthermore
overactive bladder has been shown to broadly downregulate the
expression of P2X receptors in detrusor [13,17] while conversely
P2X3 was upregulated in sensory nerve fibers from patients with
neurogenic detrusor overactivity [33]. P2X3 is also upregulated in
a model of outlet obstruction in rats [18] while human patients
with outlet obstruction had elevated P2X1 [19] and P2X2 [34]
receptors in their bladder smooth muscle. P2X2/X3 are also
elevated in urothelium of patients with interstitial cystitis [35–36].
Furthermore, visceral pain originating from tube and sac-like
Figure 6. Immunolocalization of NTPD3 in different regions of the bladder. Cryosections of mouse bladders were labeled with antibodies
to NTPD3 (green), rhodamine phalloidin to label the actin cytoskeleton (red) and Topro-3 to label nuclei (blue). Color merged panels are shown on
the right. A) NTPD3 staining at the level of the urothelium, B) NTPD3 staining at the level of the lamina propria, C) NTPD3 staining at the level of the
detrusor smooth muscle, D) NTPD3 staining with a different antibody from (A) at the level of the urothelium. Aquaporin 3 (AQP3), a marker of
intermediate and basal cell plasma membranes colocalizes with NTPD3. White scale bars =10 mm.
doi:10.1371/journal.pone.0018704.g006
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between epithelia and adjacent sensory neurons [37-41]. There-
fore painful bladder syndromes of mysterious etiology might occur
through mechanisms in which nucleotide signaling is dysregulated
or accentuated.
The existence of ATP/ADP degrading enzymes on the surface
of cells had been recognized for decades, but molecular
identification of the first member of the NTPDase family
(NTPDase 1) was not elucidated until the mid-1990s [21]. It is
now understood that these enzymes modulate purinergic signaling
through effects on ligand availability to P1 and P2 receptors in
virtually every tissue of the body and have been shown to play
important functional roles in vasculature and the immune and
nervous systems [21]. The experiments presented here, are
therefore intended to define the expression and localization
patterns of NTPDs. We believe this is the first systematic attempt
to catalog and describe the location of ectonucleotidases within the
mammalian urinary bladder.
We successfully amplified specific mRNA for all eight members
of the NTPD family as well as for NT5E, thus confirming the likely
importance of modulating nucleotide concentrations within
bladder tissue elements (Fig. 1).
Our goal in this study was to characterize the distribution of
nucleotide-hydrolyzing enzymes which could modulate the
signaling of secreted ATP/UTP. Therefore we focused in more
detail on the four cell surface localized enzymes known to
specifically catabolize extracellular ATP (NTPD1, -2, -3 and -8) as
well as NT5E. Western blotting confirmed that all five were
expressed in bladder, but using immunofluorescence we were only
able to unequivocally confirm the localization of four, since
NTPD8 exhibited low expression levels. Figure 9 schematically
illustrates our findings with each enzyme specifically expressed by
particular cell types.
NTPD1 is the major ectonucleotidase responsible for degrading
ATP within the vasculature and our data clearly show that it is
prominently expressed in endothelial cells within bladder. It has
been shown to play a key role in hemostasis and thrombosis with
complex effects on platelet aggregation [42]. It is likely therefore
that its presence in vascular elements within the bladder is not
specific to this tissue.
The presence of NTPD1 and NT5E in the cell membranes of
smooth muscle cells suggests important functional roles related to
muscle contraction and relaxation during the voiding cycle.
Indeed, concerted actions are probable given what is known of
urinary bladder smooth muscle physiology. To initiate voiding,
parasympathetic nerves release ATP to stimulate bladder smooth
muscle contraction through P2X1 receptors [6]. NTPD1, also
present on these membranes, has approximately equal affinities for
ATP and ADP [25] and is therefore able to rapidly catalyze the
production of AMP. Following the contractile phase of voiding,
NTPD1 and NT5E acting coordinately could rapidly convert ATP
to adenosine in order to not only effect cessation of P2X1-
mediated muscle contraction, but to facilitate muscle relaxation
through A2b receptors. Relaxation is clearly a prerequisite for
accommodating the next filling cycle. Support for this hypothesis
comes from studies showing that adenosine receptor, A2b is
abundantly expressed in detrusor [43], and further, that adenosine
inhibits detrusor contraction elicited through carbachol, electrical
field stimulation, acetylcholine and potassium [44–46]. This model
suggests that ATP is responsible (in part) not only for the
contractile phase but also via NTPD1/NT5E activity, the relaxant
phase of the micturition cycle and could therefore be considered a
‘dual effector’.
NTPD2 shows an interesting partial distribution in lamina
propria, being present in the deeper layer adjacent to the
detrusor (illustrated schematically in Fig. 9). Within detrusor,
Figure 7. Immunolocalization of NTPD8 in bladder and liver. Cryosections of mouse bladders and livers were labeled with antibodies to
NTPD8 (green), rhodamine phalloidin to label the actin cytoskeleton (red) and Topro-3 to label nuclei (blue). Color merged panels are shown on the
right. A) NTPD8 staining of bladder, B) NTPD8 staining of liver. White scale bars =25 mm.
doi:10.1371/journal.pone.0018704.g007
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close proximity to smooth muscle bundles. Our data show
clearly these cells are unlikely to be typical fibroblasts or nerve
fibers. In fact based on their branched morphology, network
patterning, location around muscle bundles and their intimate
association with neurons (Fig. 5c), we considered the possibility
that they might be interstitial cells of Cajal (ICC). Despite
multiple attempts with different antibodies we were unable to
immunostain for the ICC marker, c-kit. c-kit positive ICC, or
pacemaker cells, have been convincingly demonstrated in
bladders from a number of species including human [47–48],
dog [49], pig [50], and guinea pig [51–52], however studies on
bladders of mice are mixed. Lagou et al. demonstrated ICC in
mouse bladder by morphology and by pharmacological
stimulation, however ICC were c-kit negative [53]. Likewise,
Pezzone et al. also failed to detect c-kit in mouse bladder despite
finding c-kit positive cells in the ureter [54]. In contrast to this
McCloskey et al. were able to show c-kit positive cells in mouse
bladder [55]. Despite our inability to colocalize c-kit with
NTPD2, there remains a strong circumstantial case for
considering that these cells may be ICC.
There are other possibilities also. They may represent a
subgroup of myofibroblasts which do not express aSMA. Cells
matching this description were identified as myofibroblasts by Liu
et al [56]. Dranoff et al. noted that NTPD2 was present in a novel
compartment of fibroblasts in liver, namely portal fibroblasts
which surround intrahepatic bile ducts [57]. In another study,
myofibroblasts were found to exhibit close contacts with nerve
varicosities in electron micrographs and the authors speculated
that myofibroblasts and their attached axonal varicosities could
collectively function as bladder stretch receptors [58]. Our data
show similar intimate contacts between NTPD2-positive cells and
neurons. Since this ectoenzyme is highly specific for ATP over
ADP (hydrolysis ratio of 1:0.05–1:0.3) it’s primary function is likely
to be in attenuating ATP signaling [25] and generating ADP/
UDP ligands for stimulating P2Y receptors in a cellular
compartment that lies close to and surrounds the detrusor. It is
possible given not only its proximity to smooth muscle but also to
nerve fibers that it may play an important role in degrading ATP
released as a neurotransmitter from efferent neurons. Fig. 9 shows
the cross-boundary distribution of NTPD2-positive cells in both
lamina propria and between muscle bundles in the detrusor.
Figure 8. Immunolocalization of NT5E in different regions of the bladder. Cryosections of mouse bladders were labeled with antibodies to
NT5E (green), rhodamine phalloidin to label the actin cytoskeleton (red) and Topro-3 to label nuclei (blue). Color merged panels are shown on the
right. A) NT5E staining at the level of the urothelium, B) NT5E staining at the level of the lamina propria, C) NT5E staining at the level of the detrusor
smooth muscle. White scale bars =10 mm.
doi:10.1371/journal.pone.0018704.g008
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does not appear to present in umbrella cells but occurs in cell
membranes of the intermediate and basal cell layers. This explains
the observed difference in the kinetics of ATP hydrolysis on the
luminal and serosal surfaces [2]. Urothelial stretch-induced ATP
secretion lumenally, is likely to have autocrine signaling effects on
the apical membranes of umbrella cells while basal release suggests
paracrine effects serosally. A primary signaling target for the
urothelium is afferent neurons which are closely apposed to and
penetrate between basal cells of the lamina propria and even
urothelium. The signaling pathways activated by these interactions
may influence such diverse phenomena as intracellular Ca
2+
signaling action potentials and exocytosis of other potent
mediators like nitric oxide, acetylcholine and prostaglandins [5].
NTPD3 likely modulates the strength or duration of this stimulus
on the cells in which it is expressed i.e. urothelium. Indeed if the
primary target for basally secreted ATP is cells in the stroma or
detrusor, its role might be to limit the potential for self-stimulation.
It is noteworthy that none of the NTPDs were present on the
luminal surface of umbrella cells which supports the finding that
ATP released apically from urothelium is likely to be long-lived
until its expulsion with voided urine.
The location of NTPD8 was uncertain since antibody staining
was diffuse and present in several regions. There was however a
suggestion that it may be concentrated within umbrella cells.
Given the strong expression of this protein within hepatic
canaliculus of liver, an epithelial expression pattern in bladder is
entirely reasonable. It is however, present at lower levels in the
bladder than in the liver.
Figure 9 presents schematically, a simplified overview of our
findings, with the bladder structurally divided into three distinct
strata; the urothelium, lamina propria and detrusor smooth
muscle. NTPD8 and NTPD3 are present exclusively in the
epithelium with NTPD3 restricted to the suburothelium. Within
the connective tissue elements of the lamina propria, NTPD1 may
be found in blood vessels while NTPD2 occurs in a specific subset
of cells which may be ICC. Further work will be necessary to
confirm if this is true. These cells lie proximal to the smooth
Figure 9. Model of urinary bladder showing differential distribution of nucleotidases. Three tissue layers of the bladder are shown with
the cells we have identified as expressing nucleotidases. For the sake of clarity, afferent and efferent neurons have not been included. Different cell
types are color coded with the banner arrows at left indicating which colored cells express which nucleotidases. Within the lamina propria, FSP1-
positive fibroblasts and a-SMA-positive myofibroblasts localize to the suburothelial region (purple cells) and appear absent or rare closer to the
detrusor smooth muscle. The region of the lamina propria adjacent to the smooth muscle is rich in NTPD2-positive cells. They also surround and
intercalate between muscle bundles. NTPD8 is indicated in umbrella cells with a question mark to reflect a degree of uncertainty and endothelium of
blood vessels are labeled with NTPD1.
doi:10.1371/journal.pone.0018704.g009
Ectonucleotidases in Mammalian Bladder
PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e18704muscle and surround muscle bundles, but are not in the smooth
muscle itself. NTPD1 and NT5E however, are richly expressed
within the smooth muscle suggesting a functionally important
relationship.
This expression and localization study provides important novel
information about the signature of nucleotidases in mammalian
bladder. Knowledge of their tissue-specific distribution will allow
the design of rational functional studies to test the contribution of
each to normal micturition. For example the use of Cre-lox
technology to generate conditional knockouts in specific cell types
e.g. urothelium [59], can now be considered for these enzymes.
Altered purinergic signaling occurs frequently in bladder disease
and at present the involvement of ectonucleotidases in disease
processes is completely unknown. This study sets the stage for
further investigations of their role in both physiology and
pathophysiology. Furthermore, these ectoenzymes may one day
offer tempting therapeutic targets for conditions such as overactive
bladder or painful bladder syndrome.
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